4.7 Article

Hypomorphic mutations of TRIP11 cause odontochondrodysplasia

期刊

JCI INSIGHT
卷 4, 期 3, 页码 -

出版社

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/jci.insight.124701

关键词

-

资金

  1. Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [246781735 - SFB 1140]
  2. European Commission [602300, 754825]
  3. Wellcome Trust
  4. European Research Council (ERC StG TREATCilia) [716344]
  5. MRC [MR/N000366/1]
  6. H2020 Societal Challenges Programme [754825] Funding Source: H2020 Societal Challenges Programme
  7. MRC [MR/N000366/1] Funding Source: UKRI

向作者/读者索取更多资源

Odontochondrodysplasia (ODCD) is an unresolved genetic disorder of skeletal and dental development. Here, we show that ODCD is caused by hypomorphic TRIP11 mutations, and we identify ODCD as the nonlethal counterpart to achondrogenesis 1A (ACG1A), the known null phenotype in humans. TRIP11 encodes Golgi-associated microtubule-binding protein 210 (GMAP-210), an essential tether protein of the Golgi apparatus that physically interacts with intraflagellar transport 20 (IFT20), a component of the ciliary intraflagellar transport complex B. This association and extraskeletal disease manifestations in ODCD point to a cilium-dependent pathogenesis. However, our functional studies in patient-derived primary cells clearly support a Golgi-based disease mechanism. In spite of reduced abundance, residual GMAP variants maintain partial Golgi integrity, normal global protein secretion, and subcellular distribution of IFT20 in ODCD. These functions are lost when GMAP-210 is completely abrogated in ACG1A. However, a similar defect in chondrocyte maturation is observed in both disorders, which produces a cellular achondrogenesis phenotype of different severity, ensuing from aberrant glycan processing and impaired extracellular matrix proteoglycan secretion by the Golgi apparatus.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据